September 2016
Greetings!
It’s back to school time—clean slates and fresh starts. I'm pleased to offer you a resource to help educate yourself about the management of patients with multiple myeloma: the September issue of our Multiple Myeloma Updates series.
This month, I'd like to ask you to watch Chapter 8 of our roundtable discussion, in which the patient we were following develops a vertebral compression fracture. Which imaging modalities are necessary? What interventions should occur? And what is the role of bisphosphonate therapy in this setting?
To help you stay informed, I've gathered some links to MM articles recently published in the peer-reviewed literature. An exciting paper was published in the New England Journal of Medicine this month. The paper reports the results of a study that evaluated the efficacy and safety of the anti-CD38 monoclonal antibody daratumumab in combination with bortezomib, lenalidomide and dexamethasone. Be sure to check out the ASCO Post report on this below.
As always, feel free to share this MM resource, the video roundtable discussion, and the JADPRO supplement with your colleagues.
Beth Faiman, PhD, APN-BC, AOCN®
Multiple Myeloma Program
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio
